Hantz Financial Services Inc. bought a new position in UiPath Inc. (NYSE:PATH – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,244 shares of the healthcare company’s stock, valued at approximately $28,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Intech Investment Management LLC grew its stake in UiPath by 3.1% in the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after acquiring an additional 426 shares in the last quarter. Global Financial Private Client LLC boosted its stake in shares of UiPath by 9.3% during the first quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock valued at $144,000 after purchasing an additional 551 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of UiPath by 1.7% during the first quarter. Principal Financial Group Inc. now owns 36,772 shares of the healthcare company’s stock valued at $834,000 after purchasing an additional 622 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of UiPath by 40.2% during the first quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after purchasing an additional 632 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its stake in shares of UiPath by 46.0% during the first quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock valued at $46,000 after purchasing an additional 639 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on PATH shares. KeyCorp reiterated a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. TD Cowen reiterated a “hold” rating and set a $17.00 price objective (down from $28.00) on shares of UiPath in a research note on Thursday, May 30th. Canaccord Genuity Group dropped their price objective on shares of UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a research note on Friday, May 31st. JPMorgan Chase & Co. lowered their target price on shares of UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Finally, Morgan Stanley lowered their target price on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating for the company in a research note on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, UiPath currently has an average rating of “Hold” and a consensus target price of $17.94.
UiPath Price Performance
Shares of UiPath stock opened at $12.60 on Wednesday. The stock has a market cap of $7.22 billion, a PE ratio of -78.75 and a beta of 0.86. The firm has a fifty day moving average price of $12.21 and a 200 day moving average price of $16.86. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87.
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- How to Calculate Options Profits
- 3 Small Cap Stocks That Insiders Are Buying
- How to Effectively Use the MarketBeat Ratings Screener
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.